恆輝安防(300952.SZ):公司越南工廠產能建設已取得階段性進展,部分產線已經開始調試生產
格隆匯8月13日丨恆輝安防(300952.SZ)在投資者互動平臺表示,公司越南工廠產能建設已取得階段性進展,部分產線已經開始調試生產。越南關稅政策落地,原產地證辦理審覈政策持續收緊,實際審覈標準呈現動態調整態勢;另產品認證流程鏈條長、涉及部門多,顯著增加了辦理的複雜性。目前公司正全力推進產線安裝調試、產能爬坡及相關產品認證審覈工作,組建專項團隊對接各項流程,積極應對變化,爲訂單承接及產品交付做多方面的積極準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.